Related Experiment Video
Updated: Jun 5, 2026

Using Mouse Mammary Tumor Cells to Teach Core Biology Concepts: A Simple Lab Module
Published on: June 18, 2015
Tamoxifen and its new derivatives in cancer research
Claudia Rivera-Guevara1, Javier Camacho
1Department of Pharmacology, Centro de Investigación y de Estudios Avanzados, Avenida Instituto Politécnico Nacional 2508, México D. F. 07360, México.
Abstract:
A major challenge in cancer research is to discover drugs with high selectivity and minor side-effects. Tamoxifen has been widely used for more than 30 years in breast cancer treatment and prevention. Tamoxifen acts mainly via estrogen receptors (ER), but also displays anti-tumor activity in breast cancer negative to ERs, suggesting other targets. Actually, tamoxifen has effects on several transduction pathways and diverse ion channels. Despite the successful use of tamoxifen, this drug produces some non-desirable side-effects by acting on different targets. However, such non-specificity of tamoxifen might be used to unravel new targets to inhibit tumor cell proliferation, to elucidate new mechanisms of action of tamoxifen and tamoxifen analogs, and finally, to design new more specific and potent drugs on the benefit of cancer patients. This review will briefly describe first the current and general aspects of tamoxifen and then will focus more deeply on various tamoxifen analogues and new uses of tamoxifen described in recent patents. We will describe the biological effects and the therapeutic targets of the new patented analogues, in order to offer an alternative panorama on tamoxifen-based chemotherapy.
Insights
Tamoxifen, a breast cancer drug, shows anti-tumor effects beyond estrogen receptors (ER). Its non-specificity may reveal new targets for developing more potent and selective cancer therapies.
Area of Science:
- Oncology
- Pharmacology
- Drug Discovery
Background:
- Tamoxifen is a cornerstone in breast cancer treatment and prevention for over 30 years.
- While primarily targeting estrogen receptors (ER), tamoxifen exhibits anti-tumor activity in ER-negative cancers, indicating additional mechanisms.
- Tamoxifen's known side effects stem from its interactions with multiple cellular pathways and ion channels.
Purpose of the Study:
- To review current knowledge on tamoxifen and its analogues.
- To explore recent patent literature on novel tamoxifen analogues and their therapeutic applications.
- To elucidate the biological effects and therapeutic targets of new patented tamoxifen derivatives.
Main Methods:
- Literature review of tamoxifen's general aspects.
- Analysis of recent patents detailing tamoxifen analogues.
- Description of biological effects and therapeutic targets of novel analogues.
Main Results:
- Tamoxifen interacts with various cellular targets beyond estrogen receptors.
- Recent patents reveal new tamoxifen analogues with distinct biological activities.
- These analogues offer potential for targeted cancer therapy with improved specificity.
Conclusions:
- Tamoxifen's non-specific action provides opportunities to discover new anti-cancer targets.
- Novel tamoxifen analogues are emerging with potential for enhanced efficacy and reduced side effects.
- This research offers a new perspective on tamoxifen-based chemotherapy for cancer patients.
Related Concept Videos
Targeted Cancer Therapies
There are several types of targeted therapies against specific...
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase
Cancer
Mitogens and the Cell Cycle
